Clinical Trial Update: Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial update for PAN-301-1 (SNS-301) in cancer patients has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PAN-301-1 (SNS-301) (PAN-301-1)

Snippet

Sponsor: Sensei Biotherapeutics, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-11-12